Immunovant (IMVT) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.57
-0.51
-0.45
-0.39

Details

Expected EPS
-0.45
Actual EPS
-0.57
Surprise EPS
-0.12
Surprise Percent
+26.67%

Description

Immunovant (IMVT) has reported earnings of -0.57 per share for Q2 2023.

0 Comments

Share your thoughts